Tandem Diabetes Care (TNDM) Total Current Liabilities (2013 - 2026)

Tandem Diabetes Care (TNDM) has 14 years of Total Current Liabilities data on file, last reported at $248.0 million in Q1 2026.

• Quarterly Total Current Liabilities fell 13.96% year-over-year to $248.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $248.0 million (down 13.96% YoY) and the FY2025 annual result came in at $242.7 million, down 1.75% from the prior year.
• Total Current Liabilities grew to $248.0 million in Q1 2026, from $242.7 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $288.2 million in Q1 2025 to a low of $131.8 million in Q1 2022.
• A 5-year average of $209.5 million and a median of $195.3 million in 2023 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2025 — Total Current Liabilities surged 49.34% — and 2026, when it declined 13.96%.
• Tracing TNDM's Total Current Liabilities over 5 years: stood at $165.3 million in 2022, then rose by 18.13% to $195.3 million in 2023, then rose by 26.52% to $247.0 million in 2024, then decreased by 1.75% to $242.7 million in 2025, then rose by 2.16% to $248.0 million in 2026.
• The last three Total Current Liabilities figures came in at $248.0 million (Q1 2026), $242.7 million (Q4 2025), and $252.5 million (Q3 2025), per Business Quant data.